Iron Absorption From Iron-fortified Fonio Porridge: a Stable Isotope Study
NCT ID: NCT01443832
Last Updated: 2011-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2010-09-30
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study population: Sixteen apparently healthy young women aged 18-30 years recruited at the University based on their willingness to participate and according to inclusion criteria.
Study design: Fonio porridges fortified with isotopically labelled \[57Fe\] or \[58Fe\] ferrous sulfate, with (test meal) and without wheat flour (control meal) are administered to fasting subjects on two consecutive days using a randomised crossover design. Half the subjects received the test meal on the first day and the control on the second day and vice versa. No food or drink was allowed within the 3 hours after consumption. All meals were administered under close supervision. Venous blood sample were collected (day 1 and day 16) for iron status and iron absorption measurement. Iron absorption measurement is calculated based on iron isotope-dilution in erythrocyte 14 days after intake of the labelled meals.
Study parameters: Fourteen days before the test, height and weight were measured for nutritional status and subjects were screened for pregnancy and malaria. They were also treated with antihelminth (albendazole tablet). The day before meals test (day 0), whole blood sample was collected for hemoglobin (Hb), serum ferritin (SF), serum Transferrin Receptor (sTfR) and C-reactive protein (CRP). Anemia and iron deficiency was defined as Hb \< 120 g/L, and SF \< 12 µg/L respectively. Pregnancy test and malaria tests were repeated on that day. On day 1 and day 2, the fonio porridges were randomly given to the subjects on a cross-over designed. Fourteen days after the meal test (day 16) whole blood sample was collected for iron absorption measurement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
iron absorption
Fe57 and Fe58-FeSO4 stable isotopes
\[57Fe\] and \[58Fe\]- FeSO4 prepared from isotopically enriched 57Fe and 58Fe respectively, by dilution of each compound in 0.1 mol H2SO4/L.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fe57 and Fe58-FeSO4 stable isotopes
\[57Fe\] and \[58Fe\]- FeSO4 prepared from isotopically enriched 57Fe and 58Fe respectively, by dilution of each compound in 0.1 mol H2SO4/L.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* apparently healthy
* body weight \< 65 kg (confirmed by anthropometric measurement at recruitment)
* not pregnant (confirmed by pregnancy test)
* not lactating (confirmed by age of last child if any)
* no reported chronic medical illnesses (diabetes, rheumatism, high blood pressure, etc)
* no reported symptoms of malaria in the last 2 months (fever, headache, stomachache, diarrhoea, nausea, vomiting) (confirmed by malaria test)
* No severe anemia (Hb\<90 g/l)
* no intake of vitamin and mineral supplements in the last 2 weeks
* no iron medication or supplementation during the study
* no blood donation in the last 6 months
* no reported allergy to gluten
Exclusion Criteria
* pregnant
* recent fever malaria
* abnormal CRP level (\>10 mg/l)
* severe anemia (Hb \< 90g/l) and iron deficiency (serum ferritin concentration \< 12 µg/l)
18 Years
30 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Foundation for Science (IFS)
OTHER
Wageningen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Inge D Brouwer, Dr Ir
Role: STUDY_DIRECTOR
Division of Human Nutrition/Wageningen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department Nutrition and Food Science/Univsersity of Abomey calavi
Cotonou, Littoral Department, Benin
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Moretti D, Zimmermann MB, Wegmuller R, Walczyk T, Zeder C, Hurrell RF. Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans. Am J Clin Nutr. 2006 Mar;83(3):632-8. doi: 10.1093/ajcn.83.3.632.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
005/CNPERS/SA
Identifier Type: OTHER
Identifier Source: secondary_id
10/12 Fonio Study Benin
Identifier Type: -
Identifier Source: org_study_id